Antibody Drug Conjugates Market Size, Share, and Forecast by 2030
Antibody Drug Conjugates Market: Strategic Insights
Antibody Drug Conjugates Market
-
CAGR (2022 - 2030)18.2% -
Market Size 2022
US$ 7.79 Billion -
Market Size 2030
US$ 29.6 Billion
Market Dynamics
GROWTH DRIVERS
- Increase in cancer therapeutics
- Rise in demand for targeted drug delivery systems
FUTURE TRENDS
- Development of new ADC technologies
- Growing focus on targeted therapies for cancer
OPPORTUNITIES
- Expansion in oncology and immunotherapy
- Growth in drug conjugate technologies
Key Players
- ADC Therapeutics SA
- Pfizer Inc
- F Hoffmann La Roche Ltd
- ImmunoGen Inc
- GSK Plc
- Gilead Sciences Inc
- AstraZeneca Plc
- Astellas Pharma Inc
- RemeGen Co Ltd
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Technology - Cleavable Linker and Non-Cleavable Linker
Application - Blood Cancer
- Breast Cancer
- Ovarian Cancer
- Urothelial Cancer
Distribution Channel - Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Get Free Sample For